Taizhou Yueyang Pharmaceutical Development

Taizhou Yueyang Pharmaceutical Development is a specialty pharmaceutical company based in China that focuses on the development of high-end modified-release drug delivery systems. The company utilizes its proprietary controlled-release technology platforms to develop improved versions of existing medications (505(b)(2) pathway) with enhanced efficacy and safety profiles. Their pipeline primarily targets chronic conditions such as pain management, cardiovascular diseases, and metabolic disorders. Taizhou Yueyang operates a modern R&D center and manufacturing facility designed to meet international GMP standards, aiming to serve both the domestic Chinese and global markets.